1635 related articles for article (PubMed ID: 18374913)
1. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
[TBL] [Abstract][Full Text] [Related]
2. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Cavun S; Göktalay G; Millington WR
J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
[TBL] [Abstract][Full Text] [Related]
3. Aquaporin 4 deficiency modulates morphine pharmacological actions.
Wu N; Lu XQ; Yan HT; Su RB; Wang JF; Liu Y; Hu G; Li J
Neurosci Lett; 2008 Dec; 448(2):221-5. PubMed ID: 18973795
[TBL] [Abstract][Full Text] [Related]
4. Spinal antinociception of synthetic omega-conotoxin SO-3, a selective N-type neuronal voltage-sensitive calcium channel blocker, and its effects on morphine analgesia in chemical stimulus tests in rodent.
Yan LD; Liu YL; Zhang L; Dong HJ; Zhou PL; Su RB; Gong ZH; Huang PT
Eur J Pharmacol; 2010 Jun; 636(1-3):73-81. PubMed ID: 20361956
[TBL] [Abstract][Full Text] [Related]
5. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
[TBL] [Abstract][Full Text] [Related]
6. Synergistic antinociception between ZC88, an N-type voltage-dependent calcium channel blocker, and ibuprofen in mouse models of visceral and somatic inflammatory pain.
Zhou WZ; Zhao TY; Wang ZY; Lu GY; Zhang SZ; Zhang C; Wu N; Li J
Eur J Pain; 2019 Jan; 23(1):46-56. PubMed ID: 29978517
[TBL] [Abstract][Full Text] [Related]
7. Anti-allodynic interactions between NMDA receptor channel blockers and morphine or clonidine in neuropathic rats.
Malyshkin AA; Medvedev IO; Danysz W; Bespalov AY
Eur J Pharmacol; 2005 Sep; 519(1-2):80-5. PubMed ID: 16109402
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms in dizocilpine-induced attenuation of development of morphine dependence: an association with cortical Ca2+/calmodulin-dependent signal cascade.
Hamdy MM; Noda Y; Miyazaki M; Mamiya T; Nozaki A; Nitta A; Sayed M; Assi AA; Gomaa A; Nabeshima T
Behav Brain Res; 2004 Jul; 152(2):263-70. PubMed ID: 15196794
[TBL] [Abstract][Full Text] [Related]
9. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
[TBL] [Abstract][Full Text] [Related]
10. Blocking the R-type (Cav2.3) Ca2+ channel enhanced morphine analgesia and reduced morphine tolerance.
Yokoyama K; Kurihara T; Saegusa H; Zong S; Makita K; Tanabe T
Eur J Neurosci; 2004 Dec; 20(12):3516-9. PubMed ID: 15610184
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of opioid analgesic tolerance in p75 neurotrophin receptor null mutant mice.
Trang T; Koblic P; Kawaja M; Jhamandas K
Neurosci Lett; 2009 Feb; 451(1):69-73. PubMed ID: 19114089
[TBL] [Abstract][Full Text] [Related]
12. Ellagic acid enhances morphine analgesia and attenuates the development of morphine tolerance and dependence in mice.
Mansouri MT; Naghizadeh B; Ghorbanzadeh B
Eur J Pharmacol; 2014 Oct; 741():272-80. PubMed ID: 25179576
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of selective NK(1) receptor antagonist CI-1021 in animal models of inflammatory and neuropathic pain.
Gonzalez MI; Field MJ; Hughes J; Singh L
J Pharmacol Exp Ther; 2000 Aug; 294(2):444-50. PubMed ID: 10900217
[TBL] [Abstract][Full Text] [Related]
14. Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats.
Wang YX; Gao D; Pettus M; Phillips C; Bowersox SS
Pain; 2000 Feb; 84(2-3):271-81. PubMed ID: 10666532
[TBL] [Abstract][Full Text] [Related]
15. On the mechanism of cross-tolerance between morphine- and nicotine-induced antinociception: involvement of calcium channels.
Biala G; Weglinska B
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):15-21. PubMed ID: 16202496
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice.
Mika J; Wawrzczak-Bargiela A; Osikowicz M; Makuch W; Przewlocka B
Brain Behav Immun; 2009 Jan; 23(1):75-84. PubMed ID: 18684397
[TBL] [Abstract][Full Text] [Related]
17. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
18. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
Cichewicz DL; Welch SP
J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
[TBL] [Abstract][Full Text] [Related]
19. Palmitic acid analogues exhibiting antinociceptive activity in mice.
Déciga-Campos M; Montiel-Ruiz RM; Navarrete-Vázquez G; López-Muñoz FJ
Proc West Pharmacol Soc; 2007; 50():75-7. PubMed ID: 18605236
[TBL] [Abstract][Full Text] [Related]
20. [Analgesic effect of huwentoxin-I, a new N-type voltage-sensitive calcium channel blocker, on acute visceral pain in rats].
Chen JQ; Chen WH; Deng MC; Li G; Kang Y; Ding ZH; Liang SP
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jan; 25(1):10-4. PubMed ID: 15683987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
